COA verifiedAppetite, glucose, body fat
Tirzepatide
Dual GIP/GLP-1 agonist studied for substantial appetite reduction, glucose control and weight loss.
10 mg
$249

GLP-1 receptor agonist studied for appetite reduction, satiety and blood-sugar control.
Presentation
5 mg
Price
$189